Drug
Endostatins clinical trials
Also written Endostatin.
- studies test it
- 15
- open now
- 2
- in phase 3
- 2
- first study started
- 2008
Keep track of what changes. Save the Endostatins studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
15 studies that test it; most in 2011 (5)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 12
- Phase 3
- 2
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 13
Tianjin Medical University Cancer Institute and Hospital (2) · Xijing Hospital (2) · Zhejiang Cancer Hospital (2) · Sun Yat-sen University (2) · Beijing Tiantan Hospital (1) · Second Affiliated Hospital of Soochow University (1) · Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1) · Xinjiang Medical University (1)
Often tested with
Tested in the same studies.
Docetaxel (2) · Epirubicin (2) · Capecitabine (1) · Paclitaxel (1) · Carboplatin (1) · Oxaliplatin (1) · Leucovorin (1) · Fluorouracil (1)
Studies
Open first, then newest update. How each study uses Endostatins is read from its arms, and is right about nine times in ten.
Testing it · 15
- A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung CancerRecruitingPhase 2Second Affiliated Hospital of Soochow UniversityNCT06047860Written as Endostatin
- Radiotherapy Combined With Endostatin and Capecitabine for NPCRecruitingPhase 2Zhejiang Cancer HospitalNCT05514275Written as Endostatin and Capecitabine
- Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLCStatus unknownPhase 2Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityNCT05448781Written as Endostatin
- Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast CancerStatus unknownPhase 2Xinjiang Medical UniversityNCT02489409Written as EndostarTM Injection
- Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsCompletedPhase 2Beijing Tiantan HospitalNCT02104323Written as Endostatin
- E10A for the Treatment of Squamous Cell Carcinoma of the Head and NeckStatus unknownPhase 3Guangzhou Double Bioproducts Co., LtdNCT02630264Written as Endostatins
- Trial of Endostar Combined With CHOPT for T Cell LymphomaStatus unknownPhase 2Tianjin Medical University Cancer Institute and HospitalNCT01430013Written as Endostar and CHOPT
- Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLCCompletedPhase 4Tianjin Medical University Cancer Institute and HospitalNCT02497118Written as Endostatin
- Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal CarcinomaStatus unknownPhase 2Zhejiang Cancer HospitalNCT01612286Written as endostatin
- Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement UltrasonographyStatus unknownPhase 2Sun Yat-sen UniversityNCT01347424Written as Paclitaxel , carboplatin, endostatin
- Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerStatus unknownPhase 2Chinese Academy of Medical SciencesNCT01529164Written as Endostatins (Endostar)
- Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung CancerStatus unknownPhase 2Sun Yat-sen UniversityNCT01218594Written as Endostatin
- Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung CancerStatus unknownPhase 2Protgen LtdNCT01527864Written as pegylated endostatin and Paclitaxel-Carboplatin
- Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast CancerStatus unknownPhase 3Xijing HospitalNCT01479036Written as docetaxel and epirubicin plus endostatin
- Neoadjuvant Endostatin and Chemotherapy for Breast CancerCompletedPhase 2Xijing HospitalNCT00604435Written as docetaxel and epirubicin plus endostatin
Given in every arm · 1 — Endostatins is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Endostatins
Codes
What other systems call Endostatins · ClinicalTrials.gg INT008828
- MeSH (NLM) D043169EndostatinsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D043169 | Endostatins | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.